Dongying Kechuang Biochemical Co., Ltd. was established in September 2007 with a registered capital of 30 million RMB. The company is located at 756 Tuanjie Road, Guangrao Economic Development Zone, Dongying City, covering an area of approximately 50946 square meters. It is an enterprise that integrates scientific research, production, and sales of polyacrylamide.
Dongying Kechuang Biochemical Co., Ltd., as a subsidiary of Shandong Keda Group Co., Ltd., adheres to the industrial concept of "green environmental protection, efficient energy conservation" of Keda Group, continuously increases independent innovation efforts, increases scientific research investment, actively introduces advanced scientific researchers to expand the research team, and accumulates strength to build the core competitiveness of a new high-end enterprise.
The company has established long-term strategic partnerships with China University of Petroleum and China University of Geosciences, and has established research bases. The company's polyacrylamide project is based on the national "973" project of "Greatly Improving Oil Recovery". It researches, develops and produces KC series of new temperature resistant and salt resistant polymers, active polymer polymer surfactant. With acrylamide as the main body, it is made by adding a small amount of functional monomers and lipophilic groups through static hydrolysis, homopolymerization, hydrolysis, copolymerization and other processes. Mainly used for direct injection of oilfield wastewater for polymer flooding and post polymer flooding operations. The common anionic, non-ionic, cationic, zwitterion and other polyacrylamide products produced by the company can be widely used in drilling, water plugging and profile control, papermaking, mineral processing, sewage treatment and other fields. At present, the company's products have been sold to major domestic oil fields such as Daqing, Shengli, Dagang, Xinjiang, North China, Henan, as well as countries and regions such as Canada, Kazakhstan, Albania, Indonesia, Russia, and have received good reviews from customers.
As of now, the company has a total of 34 authorized patents, including 4 invention patents and 30 utility model patents.
With the development path of continuous technological innovation and new product research and development, the company has become a leading enterprise in the industry with outstanding technology research and development capabilities, obvious product differentiation characteristics, and leading core competitiveness advantages.
